Cecilia H. Fuglsang

Department of Clinical Epidemiology, Aarhus University
Aarhus N, Midtjylland, Denmark

Novo Nordisk (Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• High-intensity versus Low- or Moderate-intensity Statin Treatment for Patients with Ischemic Stroke: Nationwide Cohort Study

  Saturday, August 27, 2022
  2:15 PM – 2:30 PM CEST